FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 22965975 · Received September 4, 2025

Report

Report Number
1823260-2025-02742
Event Type
Malfunction
Date Received
September 4, 2025
Date of Event
August 17, 2025
Report Date
September 23, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CALIBRATION AND QC WERE ACCEPTABLE FOR BOTH ASSAYS. THERE IS NO INDICATION OF A REAGENT PERFORMANCE ISSUE. THERE WERE MULTIPLE ABNORMAL ASPIRATIONS AND SAMPLE SHORT ALARMS NOTED ON THE DATE OF THE EVENT, NEAR THE TIME THE SAMPLE WAS PROCESSED. THE FIELD SERVICE ENGINEER (FSE) FOUND THE RINSE BATH CELLS WERE OVERFLOWING DUE TO A BLOCKED VACUUM VALVE. THE FSE CLEANED THE VALVE AND PERFORMED A PRECISION CHECK WITH NO ISSUES. THE CELLS WERE BEING EVACUATED CORRECTLY. THE INVESTIGATION DETERMINED THE EVENT WAS DUE TO A MAINTENANCE ISSUE.

Additional Manufacturer Narrative · 0

THE CA2 REAGENT LOT NUMBER WAS 880047 WITH AN EXPIRATION DATE OF 31-AUG-2026. THE GLUC3 REAGENT LOT NUMBER WAS 860069 WITH AN EXPIRATION DATE OF 31-MAY-2026.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF DISCREPANT LOW RESULTS FOR 1 PATIENT SAMPLE TESTED FOR CALCIUM GEN.2 (CA2) AND GLUCOSE HK GEN.3 (GLUC3) ON A COBAS C 503 ANALYTICAL UNIT. THE INITIAL CA2 RESULT WAS 5.1 MG/DL. THE REPEAT RESULT WAS 7.9 MG/DL. THE INITIAL GLUC3 RESULT WAS 49 MG/DL. THE REPEAT RESULT WAS 104 MG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2412557 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown